Bli medlem
Bli medlem

Du är här

2017-02-09

Acarix AB: Acarix AB (publ) to present at Vator Securities Unicorn Summit on 7 March 2017

Acarix AB's (publ) ("Acarix") CEO, Søren Rysholt Christiansen, will be
presenting at Vator Securities Unicorn Summit in Stockholm on 7 March 2017.
Following its listing on Nasdaq First North Premier in Stockholm in December,
Acarix will provide an update on upcoming activities for its CE-marked
CADScor®System which provides non-invasive, radiation-free acoustic rule-out
of Coronary Artery Disease (CAD) within minutes.

Vator Securities Unicorn Summit is a capital markets day with some of the most
interesting and innovative companies in Sweden. Beyond company presentations,
participants are offered a unique opportunity to network with industry peers
and investors.

More information and registration will soon be available
atwww.vatorsecurities.se

Contacts:

Acarix A/S:

Søren Rysholt Christiansen, CEO

E-mail:dksrc@acarix.com

Phone: +45 2777 1112

Notes to editors:

Acarix , CADScor®System and cardiac sound measurement

Acarix A/S was established in 2009, and since 2010 investors SEED Capital (DK)
and Sunstone Life Science Ventures (DK) have supported it towards market
introduction. Acarix has attracted a highly-experienced management team who
have held senior positions in international medical device companies - CEO
Søren Rysholt Christiansen with ELOS Medtech, GN ReSound and Cook Medical.

Acarix's CADScor®System is based on engineering excellence in sound recording
and signal processing. It has long been known that both cardiac contraction
movement and turbulent flow can generate sound. Contraction related sounds
are in lower frequency, whereas turbulent sounds in the streaming blood
caused by partial obstruction (stenosis) in the coronary arteries are of
higher frequencies. The detection of these murmurs is delicate, since the
energy of the murmurs is very weak. Detecting and recording the coronary
murmurs requires not only an advanced sensor but also means for proper
attachment to the skin above the heart to optimize the recorded signal and to
avoid external noise.

The Acarix CADScor®System has been designed to be an all-in-one system in the
sense that the heart signal will be recorded, processed and displayed as a
patient specific score, the CAD-score, on the device screen. The
CADScor®System contains the necessary electronics to instruct professionals
during use and guide the patient through the recording periods. The system
also contains a docking station for daily qualification of the sensor.
Further the system integrates with an adhesive patch for locking the CADScor®
sensor to a fixed position above the heart during the recording.

The software embedded in The Acarix CADScor®System ensures that adequate
recording conditions are controlled at every examination, whether performing
your examinations in a quiet clinical settings or at busy GP clinics, at high
altitudes (>95% coverage) or on the move.

The CADScor®System is CE Marked (by TÜV in 2015) and due for commercial launch
in 2017.

See more atwww.acarix.com

20170209 Press Release - Unicorn Summit
http://hugin.info/173338/R/2076950/781191.pdf

---------------------------------------
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Acarix AB via Globenewswire

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.